BSE: 532540 NSE: Astrazenca Pharma India ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
Astrazenca Pharma India Overview:
|Stock Symbol in NSE||Stock Symbol in BSE||Current Price||Market Cap. (Cr)||P/E Ratio||Current EPS|
Astrazenca Pharma India Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
<Space for Feature Image>
- Astrazenca Pharma India is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
|Year||Mar 2009||Mar 2010||Mar 2011||Mar 2012||Mar 2013||Mar 2014||Mar 2015||Mar 2016||Mar 2017||Mar 2018||Mar 2019||Mar 2020|
Astrazenca Pharma India Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
|Next 5 Year (CG)||Next 10 Year (CG)||Next 20 Year (CG)|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
|Next 5 Year (CG+5%)||Next 10 Year (CG+10%)||Next 20 Year (CG+20%)|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
|Next 5 Year (CG-5%)||Next 10 Year (CG-10%)||Next 20 Year (CG-20%)|
Astrazenca Pharma India Quarterly Result, Date & Street Estimate:
Fundamental Analysis of Astrazenca Pharma India:
Astrazenca Pharma India Share Long Term Investment Price Target:
|V-Guard Long Term Investment Tagets||Price||Qnt.Ratio|
Astrazenca Pharma India Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of Astrazenca Pharma India
- Strengths Analysis will coming Soon.
- Weakness Analysis will coming Soon.
- Opportunity Analysis will coming Soon.
- Threats Analysis will coming Soon.
Where we can See Astrazenca Pharma India in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of Astrazenca Pharma India:
Astrazenca Pharma India Share Weekly Swing Trading Price Target:
|Demand And Supply Zone||Support Levels||Support Price||Resistance Levels||Resistance Price|
Astrazenca Pharma India Share Today Intraday Price Target:
|V-Guard Share Price IntradayTarget Today [Short Selling]||V-Guard Share Price IntradayTarget Today [Long Buying]|
FAQ on Astrazenca Pharma India:
Yes, Astrazenca Pharma India is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
Astrazenca Pharma India is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently Astrazenca Pharma India is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic Astrazenca Pharma India Share drastically fall.
Its depend on when you and at what price you have buy this share, Astrazenca Pharma India at 20-25 P/E Ration is a excellent buy call for long Term Investment.
Astrazenca Pharma India’s Products/Projects:
IPO, Split, Bonus, Dividend Buyback History:
Astrazenca Pharma India First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
|CEO Name||Gagandeep Singh Bedi|
|CFO Name||Rajesh MARWAHA|
|Company Address||336/704, Ground Floor, Jamal Rd, Budh Vihar, Fraser Road Area, Patna, Bihar 800001|
|Contact Number||098350 39984|
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.